# Nasdaq's Wild Ride: Microcap Madness Unleashed!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2026-06-24T14:01:00.259Z
Source: https://newsyai.com/edition/8431fa53-e47b-43ea-800f-8e7a208c9bc1
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

**Nasdaq's Split Circus: WOK, FCUV & ILLR Microcap Mayhem!**[[1]](https://finance.yahoo.com/calendar/splits/)

Futures mixed (Dow flat, Nasdaq riding AI/chip rotation and Iran deal vibes), crude still high as a kite. Post-holiday? Markets are buzzing with low-float squeezes, fresh reverse-split desperation, deficiency letters, and dilution dick-punches. New Nasdaq/NYSE rules are tightening the reverse-split noose on serial offenders. Yesterday’s YYGH/AMIX/EHGO limp-dicks left stains; today’s drama features fresh meat chasing $1 bids amid governance ghosts and thin-float retail frenzy. Bulls scream “listing saved, moonshot reloaded”; bears howl “next equity gangbang, sub-penny doom!” Balls-deep into three fresh volatility kings.[[2]](https://www.tradingview.com/markets/stocks-usa/market-movers-most-volatile/)

### 1) WORK Medical Technology Group LTD (WOK): “1-for-100 Reverse-Split Stiffy vs. AI Med-Tech Hype & Serial Split Hangover”

**Why it’s loud**  
Brutal 1-for-100 reverse split effective June 18, 2026, to chase Nasdaq bid-price compliance (after earlier ones in 2025). China-based medical devices supplier with AI/blood cell analyzer and Web3.0 whispers; retail sniffing “post-split bounce + U.S. subsidiary growth”; bears flag repeated split vibes, thin fundamentals, and compliance theater.[[3]](https://finance.yahoo.com/markets/stocks/articles/medical-announces-1-100-reverse-130000864.html)

**Bull case (compliance cock rocket redux)**  
Thin float + split to $1+ bid + AI/med-tech narrative oxygen = parabolic rebound to $5–15+. Ape the listing save and analyzer stiffy!

**Bear case (dilution rape & split limp encore)**  
Insane 100:1 ratio screams desperation, heavy overhang + past declines = sub-$0.50 bust. Short the limp before the next notice!

**My take, first principles (real med signal vs. capital-structure cancer)**  
Legitimate bid-price fix provides short-term breathing room in a hot low-float environment, but the nuclear 100:1 ratio and microcap thinness scream unsustainable structures under the new tighter Nasdaq rules. Real compliance play with real dilution risk. Scalp the spunk? **$0.50–4**, **$1.80C** volume stiffy—**P$0.40** fade.

### 2) Focus Universal Inc. (FCUV): “Extreme Volatility Spike vs. Reverse-Split Echoes & Halt Drama”

**Why it’s loud**  
Massive swings (up 89%+ intraday, 239% volatility) on microcap retail frenzy post-reverse split and capital actions; trading halts/news pending add fuel. Bulls chase momentum in a low-float squeeze; bears hammer boom-bust patterns and thin results.[[4]](https://www.tradingview.com/symbols/NASDAQ-FCUV/)

**Bull case (squeeze cock rocket)**  
Thin float + retail ape frenzy + any narrative oxygen = parabolic moves to $8–20+. Ride the wave!

**Bear case (dump rape & limp encore)**  
Boom-bust history, profit-taking pressure + halts = sub-$1 crash. Fade the limp before the next dump!

**My take, first principles (real momentum signal vs. structural cancer)**  
Legitimate low-float fuel delivers short-term fireworks, but microcap thinness and repeated compliance/reverse-split history underscore unsustainable structures. Real volatility play with real fade risk. Scalp the spunk? **$1–6**, **$3C** hype pump—**P$0.80** fade.

### 3) Triller Group Inc. (ILLR): “1-for-10 Reverse-Split Hype vs. Social/Fintech Dreams & Nasdaq Exception Ghosts”

**Why it’s loud**  
1-for-10 reverse split effective June 23, 2026, amid Nasdaq bid-price exception to June 30 and past deficiencies/suspensions. Social media/fintech/combat sports play with retail chase potential—bulls see “post-split lift + creator-centric reset”; bears hammer execution risks, governance, and dilution ghosts.[[5]](https://www.cnn.com/markets/stocks/ILLR)

**Bull case (social cock rocket)**  
Sector tailwinds (social/fintech) + split mechanics + volume = $2–8+ rebound. Ape the creator stiffy!

**Bear case (delisting rape & burn limp)**  
Repeated compliance theater, thin results = sub-$0.50 crash. Short the limp before the next notice!

**My take, first principles (real platform signal vs. listing cancer)**  
Genuine social/fintech narrative offers narrative fuel, but microcap scale, compliance clock, and governance red flags under stricter reverse-split rules highlight classic volatility trap. Real pivot hype with real delisting risk. Scalp the spunk? **$0.40–3**, **$1.20C** pump—**P$0.30** fade.

**Tape-Side Tactics (WOK Split Grab, FCUV Volatility Squeeze & ILLR Notice Pump – June 24 Edition)**  
- **WOK**: **$0.50–4** compliance stiffy; **$1.80C** med-tech pump, **P$0.40** dilution fade.  
- **FCUV**: **$1–6** squeeze stiffy; **$3C** retail pump, **P$0.80** halt fade.  
- **ILLR**: **$0.40–3** social stiffy; **$1.20C** fintech pump, **P$0.30** exception fade.  

New split rules tightening the screws amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions!

**Sources** (for tracking every claim above):  
- Reverse splits & reactions: NasdaqTrader.com, StockTitan, Yahoo Finance, GlobeNewswire (June 2026 data).[[6]](https://nasdaqtrader.com/Trader.aspx?id=archiveheadlines&cat_id=105)  
- Nasdaq reverse-split rule changes & compliance: NasdaqTrader, SEC filings (2025-2026 updates).  
- Broader microcap/premarket context & volatility: TradingView, TipRanks, Benzinga (June 2026).  
- Company specifics via recent filings and exchange alerts.
